Search Query :
10LW
Final adduct of human ornithine aminotransferase inactivated by (1r,4s)-4-amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid Deposition Author(s): Liu, D. , Vargas, A.L.
Date: 2026-01-27 Method: X-RAY DIFFRACTION Resolution: 1.93 Å Organism(s): Homo Sapiens Sequences Data: 10LW_A , 10LW_B , 10LW_C
10LX
High stable quinonoid intermediate of human ornithine aminotransferase complexed with (1r,4s)-4-amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid Deposition Author(s): Liu, D. , Vargas, A.L.
Date: 2026-01-27 Method: X-RAY DIFFRACTION Resolution: 1.83 Å Organism(s): Homo Sapiens Sequences Data: 10LX_A , 10LX_B , 10LX_C
10MN
Crystal structure of human ogg1 (wt) in a product bound state in the presence of the agonist f51 Deposition Author(s): Arvai, A.S. , Lloyd, R.S. , Syed, A. , Tainer, J.A.
Date: 2026-01-27 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 10MN_A , 10MN_C , 10MN_B , 10MN_D
10MU
Sars-cov-2 s2 in complex with polyclonal fab_donor2 Deposition Author(s): Park, S. , Ward, A.B.
Date: 2026-01-28 Method: ELECTRON MICROSCOPY Resolution: 3.16 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 10MU_A , 10MU_B , 10MU_C , 10MU_D , 10MU_E
10MV
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors complex with compound 15 ((3'r)-1'-(5-amino-1-phenyl-1h-pyrazole-4-carbonyl)-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one) Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Ogawa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-28 Method: X-RAY DIFFRACTION Resolution: 1.66 Å Organism(s): Homo Sapiens Sequences Data: 10MV_A
10MW
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 25 ((3'r)-1'-{(1p)-5-amino-1-[2-(trifluoromethoxy)phenyl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one) Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , Hicks, J. , Hruza, A. , Je, J. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Poiou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-28 Method: X-RAY DIFFRACTION Resolution: 1.62 Å Organism(s): Homo Sapiens Sequences Data: 10MW_A
10NU
Structure of kras g12c bound to inhibitor 13ab Deposition Author(s): Milligan, C. , Peters, U. , Shaffer, P.L.
Date: 2026-01-29 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Homo Sapiens Sequences Data: 10NU_A , 10NU_B
10NV
Structure of kras g12c bound to inhibitor 13ba Deposition Author(s): Milligan, C. , Shaffer, P.L.
Date: 2026-01-29 Method: X-RAY DIFFRACTION Resolution: 1.52 Å Organism(s): Homo Sapiens Sequences Data: 10NV_A , 10NV_B
10OO
Fgfr2 mutant d650v with compound 4 (azd3463) Deposition Author(s): Hoffman, I.D. , Nelson, K.J.
Date: 2026-01-29 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 10OO_A , 10OO_B
10OP
Cryo-em structure of sudan ebolavirus gp bound by three neutralizing antibodies 545s, 523s and 294s Deposition Author(s): Cheng, J. , Kwong, P.D. , Misasi, J. , Pierson, T.C. , Sullivan, N.J. , Zhao, B. , Zhou, T.
Date: 2026-01-29 Method: ELECTRON MICROSCOPY Resolution: 2.63 Å Organism(s): Homo Sapiens , Sudan Ebolavirus Sequences Data: 10OP_A , 10OP_C , 10OP_E , 10OP_B , 10OP_D , 10OP_F , 10OP_G , 10OP_I , 10OP_K , 10OP_H , 10OP_J , 10OP_L , 10OP_M , 10OP_O , 10OP_Q , 10OP_N , 10OP_P , 10OP_R , 10OP_S , 10OP_U , 10OP_W , 10OP_T , 10OP_V , 10OP_X